Cite

HARVARD Citation

    Rolff, J. et al. (2009). Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers. Journal of oncology. p. . [Online]. 
  
Back to record